143 related articles for article (PubMed ID: 15664860)
1. Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamides.
Hashimoto K; Tatsuta M; Kataoka M; Yasoshima K; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta JB; Urbahns K
Bioorg Med Chem Lett; 2005 Feb; 15(3):799-803. PubMed ID: 15664860
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides.
Li Y; Kataoka M; Tatsuta M; Yasoshima K; Yura T; Urbahns K; Kiba A; Yamamoto N; Gupta JB; Hashimoto K
Bioorg Med Chem Lett; 2005 Feb; 15(3):805-7. PubMed ID: 15664861
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives.
Tatsuta M; Kataoka M; Yasoshima K; Sakakibara S; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta J; Urbahns K
Bioorg Med Chem Lett; 2005 May; 15(9):2265-9. PubMed ID: 15837306
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition.
Hashimoto K; Kataoka M; Tatsuta M; Yasoshima K; Yamamoto M; Yura T; Yamamoto N; Urbahns K; Gupta JB; Li Y
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1314-7. PubMed ID: 16204990
[TBL] [Abstract][Full Text] [Related]
5. Parallel synthesis of 2-aryl-4-aminobenzimidazoles and their evaluation as gonadotropin releasing hormone antagonists.
Green DM; Goljer I; Andraka DS; Chengalvala M; Shanno L; Hurlburt W; Pelletier JC
J Comb Chem; 2009; 11(1):117-25. PubMed ID: 19049392
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
[TBL] [Abstract][Full Text] [Related]
7. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
8. Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template.
Hauze DB; Chengalvala MV; Cottom JE; Feingold IB; Garrick L; Green DM; Huselton C; Kao W; Kees K; Lundquist JT; Mann CW; Mehlmann JF; Rogers JF; Shanno L; Wrobel J; Pelletier JC
Bioorg Med Chem Lett; 2009 Apr; 19(7):1986-90. PubMed ID: 19251413
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues.
Randolph JT; Waid P; Nichols C; Sauer D; Haviv F; Diaz G; Bammert G; Besecke LM; Segreti JA; Mohning KM; Bush EN; Wegner CD; Greer J
J Med Chem; 2004 Feb; 47(5):1085-97. PubMed ID: 14971889
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline and benzimidazole MCH-1R antagonists.
Arienzo R; Cramp S; Dyke HJ; Lockey PM; Norman D; Roach AG; Smith P; Wong M; Wren SP
Bioorg Med Chem Lett; 2007 Mar; 17(5):1403-7. PubMed ID: 17178222
[TBL] [Abstract][Full Text] [Related]
13. A new class of potent nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists: design and synthesis of 2-phenylimidazo[1,2-a]pyrimidin-5-ones.
Sasaki S; Imaeda T; Hayase Y; Shimizu Y; Kasai S; Cho N; Harada M; Suzuki N; Furuya S; Fujino M
Bioorg Med Chem Lett; 2002 Aug; 12(16):2073-7. PubMed ID: 12127507
[TBL] [Abstract][Full Text] [Related]
14. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists.
Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP
Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bioactivities of new LHRH antagonists containing a novel unnatural amino acids at position five.
Liu KL; He BL; Xiao SB; Xia QM; Fang X; Wang ZY
Sci China B; 1991 Feb; 34(2):201-8. PubMed ID: 2021421
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
